Leuprolide Not Yet Recruiting Phase 3 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04302454Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy